EU Valletta Alliance Ups The Ante On Drug Pricing Transparency
Executive Summary
EU countries should use a milestone World Health Organization resolution calling for more transparency on net medicine prices to help secure better access to medicine, says the Valletta group.
You may also be interested in...
Europe’s Biggest Multi-Country Access Alliance Picks Up The Pace
The Valletta Group says that cancer drugs, treatments for autoimmune diseases, orphan medicines and biosimilars are among the products it is targeting in its joint procurement efforts.
Italy To Consult On Pricing Transparency Requirements
Draft guidelines due out for consultation this week in Italy are expected to shed more light on what companies will have to reveal during pricing and reimbursement negotiations.
Where Now For Italy’s Drug Price Transparency Crusade?
The signs suggest that Nicola Magrini, the new director general of the Italian medicines regulator, AIFA, will follow in the footsteps of his predecessor in fighting for transparency in drug pricing.